We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Settles BYU's Long-Running Celebrex Suit

Law360, New York (May 1, 2012, 5:11 PM EDT) -- Pfizer Inc. said Tuesday that it has settled Brigham Young University's long-running contract and trade secrets lawsuit that claimed one of the school's professors discovered the enzyme behind the development of the drugmaker's anti-inflammatory drugs Bextra and Celebrex.

Both parties declined to release details of the settlement, which had not yet been filed with the District of Utah federal court at press time.

The settlement will resolve close to six years of litigation in which BYU accused Pfizer of breaching two parts of a research agreement originally signed by the university and co-defendant Monsanto Co., the pharmaceutical wing of which is...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Utah

Nature of Suit

Contract: Other

Judge

Subscribers Only

Date Filed

October 18, 2006

Law Firms

Companies